March 21, 2018 / 8:20 PM / 8 months ago

BRIEF-Sophiris Bio Q4 Loss Per Share $0.13

March 21 (Reuters) - Sophiris Bio Inc:

* SOPHIRIS BIO REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND KEY CORPORATE HIGHLIGHTS

* Q4 LOSS PER SHARE $0.13

* Q4 EARNINGS PER SHARE VIEW $-0.11 — THOMSON REUTERS I/B/E/S

* SOPHIRIS - EXPECTS CASH & CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATIONS TO MIDDLE OF 2019, ASSUMING NO NEW CLINICAL TRIALS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below